King Pharmaceuticals (KG) Buys AVINZA Rights from Ligand Pharmaceuticals (LGND)
Tweet Send to a Friend
King Pharmaceuticals, Inc. (NYSE: KG) entered into a definitive asset purchase agreement and related agreements with Ligand Pharmaceuticals Incorporated (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE